HomeRNTX • NASDAQ
add
Rein Therapeutics Inc
Previous close
$1.39
Day range
$1.36 - $1.46
Year range
$1.05 - $3.50
Market cap
38.39M USD
Avg Volume
1.82M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.49M | -9.54% |
Net income | -5.58M | 4.55% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.49M | 9.54% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.05M | -77.07% |
Total assets | 53.71M | -48.47% |
Total liabilities | 7.52M | -16.35% |
Total equity | 46.19M | — |
Shares outstanding | 26.29M | — |
Price to book | 27.80 | — |
Return on assets | -24.70% | — |
Return on capital | -29.15% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -5.58M | 4.55% |
Cash from operations | -3.55M | 7.10% |
Cash from investing | — | — |
Cash from financing | 1.90M | 526.01% |
Net change in cash | -1.67M | 60.75% |
Free cash flow | -4.18M | -77.61% |
About
Founded
2001
Headquarters
Website
Employees
11
